Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

209
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
209
Dementia01:30

Dementia

96
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
96
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualized mapping of functional brain networks in older adulthood.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Circulating lipids are related to longitudinal changes of ATN biomarkers for Alzheimer's disease.

Molecular psychiatry·2026
Same author

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine Learning.

bioRxiv : the preprint server for biology·2026
Same author

MIND diet moderates the associations between cerebrovascular and neurodegenerative disease burden and cognition.

Frontiers in nutrition·2026
Same author

Evaluation of an in vivo biomarker of arteriolosclerosis (ARTS) and its associations with cognition and multimodal ATN(V) biomarkers in a cardiometabolic-risk enriched community cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

94

Neuroimaging in Dementia.

Shannon L Risacher

    Continuum (Minneapolis, Minn.)
    |December 2, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Neuroimaging biomarkers are crucial for diagnosing and monitoring neurodegenerative diseases like Alzheimer's. Advances in MRI and PET imaging support new treatments and diagnostic frameworks.

    More Related Videos

    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    21.6K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.6K

    Related Experiment Videos

    Last Updated: Jun 6, 2025

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
    05:17

    Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

    Published on: April 18, 2025

    94
    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    21.6K
    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
    14:27

    Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

    Published on: June 26, 2013

    15.6K

    Area of Science:

    • Neurology and Neuroscience
    • Medical Imaging
    • Biomarker Discovery

    Background:

    • Neurodegenerative diseases impact millions globally, necessitating advanced diagnostic tools.
    • Neuroimaging biomarkers are integral to the detection, monitoring, and treatment of these conditions.
    • Recent therapeutic advancements, particularly for Alzheimer disease, underscore the role of imaging.

    Purpose of the Study:

    • To review current literature on neuroimaging in neurodegenerative diseases.
    • To highlight recent developments in neuroimaging techniques and their applications.
    • To discuss the integration of neuroimaging with novel therapeutic strategies and diagnostic frameworks.

    Main Methods:

    • Review of studies utilizing structural and functional Magnetic Resonance Imaging (MRI).
    • Analysis of research employing Positron Emission Tomography (PET) and Single-Photon Emission Computerized Tomography (SPECT).
    • Examination of biomarker-based diagnostic systems, including the Alzheimer disease Amyloid, Tau, Neurodegeneration (A/T/N) framework.

    Main Results:

    • Neuroimaging measures are essential biomarkers for diagnosing diverse neurodegenerative diseases.
    • MRI and PET are critical for eligibility and monitoring of new anti-amyloid therapies in Alzheimer disease.
    • Biomarker-based diagnostic frameworks, like A/T/N, are being developed for various neurodegenerative conditions.

    Conclusions:

    • Neuroimaging plays a pivotal role in the evolving landscape of neurodegenerative disease diagnosis and management.
    • The integration of advanced imaging techniques with biological frameworks enhances diagnostic accuracy and therapeutic monitoring.
    • Continued research in neuroimaging is vital for addressing the global health challenge of neurodegenerative diseases.